Skip to main content

Advertisement

Log in

The ocular manifestations of atopic dermatitis and rosacea

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Atopic dermatitis and rosacea are chronic diseases that have both dermatologic and ocular manifestations. The occurence of ocular disease is often proportionately higher than that of dermatologic disease. Even if the skin abnormalities appear well controlled, these patients require ophthalmic evaluation as well. Optimal management usually requires a team approach that includes internists, dermatologists, and ophthalmologists. Both disorders are characterized by acute exacerbations and require maintenance therapy for control. Exacerbations need aggressive treatment to limit ocular signs and symptoms and to reduce ocular inflammation that can lead to permanent visual loss. Topical corticosteroid use, although at times needed, should be minimized for both disorders. Future research will continue to emphasize the use of steroid-sparing and immune-modulating agents that have the potential to provide long-lasting anti-inflammatory control with a more favorable side-effect profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Foster CS, Calonge M: Atopic keratoconjunctivitis. Ophthalmology 1990, 97:992–1000.

    PubMed  CAS  Google Scholar 

  2. Zug DA, Palay DA, Rock B: Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol 1996, 40:293–306.

    Article  PubMed  CAS  Google Scholar 

  3. Svensson A, Moller H: Eyelid dermatitis: the role of atopy and contact allergy. Contact Dermatitis 1986, 15:178–182.

    Article  PubMed  CAS  Google Scholar 

  4. Nethercott JR, Nield G, Holness DL: A review of 79 cases of eyelid dermatitis. J Am Acad Dermatol 1989, 21:223–230.

    Article  PubMed  CAS  Google Scholar 

  5. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ: Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991, 98:150–158.

    PubMed  CAS  Google Scholar 

  6. Casey R, Abelson MB: Atopic keratoconjunctivitis. Int Ophthalmol Clin 1997, 37:111–117.

    Article  PubMed  CAS  Google Scholar 

  7. Nakata K, Inoue Y, Harada J, et al.: A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology 2000, 107:2167–2171.

    Article  PubMed  CAS  Google Scholar 

  8. Inoue Y: Ocular infections in patients with atopic disease. Int Ophthalmol Clin 2002, 42:55–69. rough review of the problems patients with atopic dermatitis can have with ocular infections. Review also discusses the potential need for antibiotic prophylaxis before ocular surgery

    PubMed  Google Scholar 

  9. Harrison RJ, Klouda PT, Easty DL, et al.: Association between keratoconus and atopy. Br J Ophthalmol 1989, 73:816–822.

    PubMed  CAS  Google Scholar 

  10. Jujo K, Renz H, Abe J, et al.: Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992, 90:323–331.

    Article  PubMed  CAS  Google Scholar 

  11. Tang MLK, Varigos G, Kemp AS: Reduced interferongamma secretion with increased interferon-gamma mrna expression in atopic dermatitis: evidence for a post-transcriptional defect. Clin Exper Immunol 1994, 97:483–490.

    Article  CAS  Google Scholar 

  12. Rikkers SM, Holland GN, Drayton GE, et al.: Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003, 135:297–302. Immune-modulating and steroid-sparing agents may hold promise for the treatment of atopic dermatitis of the eyelid by reducing inflammation while minimizing the potentially serious side effect of topical steroids

    Article  PubMed  CAS  Google Scholar 

  13. Freeman AK, Serle J, VanVeldhuisen P, et al.: Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004, 73:267–271.

    PubMed  Google Scholar 

  14. Akpek EK, Dart JK, Watson S, et al.: A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004, 111:476–482. New ophthalmic steroid-sparing topical agents may hold great promise for the treatment of even severe atopic keratoconjunctivitis.

    Article  PubMed  Google Scholar 

  15. Knox CM, Smolin G: Rosacea. Int Ophthalmol Clin 1997, 37:29–40.

    Article  PubMed  CAS  Google Scholar 

  16. Browning DJ, Proia AD: Ocular rosacea. Surv Ophthalmol 1986, 31:145–158.

    Article  PubMed  CAS  Google Scholar 

  17. Driver PJ, Lemp MA: Meibomian gland dysfunction. Surv Ophthalmol 1996, 40:343–367.

    Article  PubMed  CAS  Google Scholar 

  18. Bernardini FP, Kersten RC, Khouri LM, et al.: Chronic eyelid lymphedema and acne rosacea. Ophthalmology 2000, 107:2220–2223.

    Article  PubMed  CAS  Google Scholar 

  19. Chen DM, Crosby DL: Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol 1997, 37:346–348.

    PubMed  CAS  Google Scholar 

  20. McMulley JP, Dougherty JM, Deneau DG: Classification of chronic blepharitis. Ophthalmology 1982, 89:1173–1180.

    Google Scholar 

  21. Bleicher PA, Charles JH, Sober AJ:. Topical metronidazole therapy for rosacea. Arch Dermatol 1987, 123609–12614.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew S. Eiseman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eiseman, A.S. The ocular manifestations of atopic dermatitis and rosacea. Curr Allergy Asthma Rep 6, 292–298 (2006). https://doi.org/10.1007/s11882-006-0062-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-006-0062-z

Keywords

Navigation